These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 22412130)

  • 21. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
    Saadati H; Saif MW
    JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiotherapy: the importance of local control in pancreatic cancer.
    Ben-Josef E; Lawrence TS
    Nat Rev Clin Oncol; 2011 Nov; 9(1):9-10. PubMed ID: 22124368
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
    Czito BG; Willett CG; Bendell JC; Morse MA; Tyler DS; Fernando NH; Mantyh CR; Blobe GC; Honeycutt W; Yu D; Clary BM; Pappas TN; Ludwig KA; Hurwitz HI
    J Clin Oncol; 2006 Feb; 24(4):656-62. PubMed ID: 16446337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma.
    Hall WA; Dawson LA; Hong TS; Palta M; Herman JM; Evans DB; Tsai S; Ferrone CR; B Fleming J; Chang DT; Crane C; Koong AC; Oar A; Parikh P; Erickson B; Hoffe S; Goodman KA
    J Clin Oncol; 2021 Dec; 39(34):3773-3777. PubMed ID: 34623894
    [No Abstract]   [Full Text] [Related]  

  • 26. Ultrasound-stimulated microbubbles enhancement of fractionated radiation for tumor treatment.
    Sharma D; McNabb E; Law N; Cumal A; Czarnota GJ
    BMC Cancer; 2023 Jul; 23(1):693. PubMed ID: 37488490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
    Falco M; Masojć B; Sulikowski T
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry.
    Eckstein J; Choi JI; Lozano A; Ohri N; Press R; Hasan S; Kabarriti R; Chang J; Urbanic J; Durci M; Mohammed N; Stevens C; Tsai H; Apisarnthanarax S; Regine W; Vargas C; Nichols R; Herman J; Simone CB; Chhabra A
    Adv Radiat Oncol; 2023; 8(5):101250. PubMed ID: 37408677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.
    Doppenberg D; Lagerwaard FJ; van Dieren S; Meijerink MR; van der Vliet JJ; Besselink MG; van Tienhoven G; Versteijne E; Slotman BJ; Wilmink JW; Kazemier G; Bruynzeel AME
    Front Oncol; 2023; 13():1149961. PubMed ID: 37324027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study.
    Chen S; Li J; Dong A; Liu Z; Zhu M; Jin M; Wei G; Wu S; Wang Y; Chen Y; Peng Z
    J Hematol Oncol; 2023 Mar; 16(1):26. PubMed ID: 36941671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials.
    Jin SF; Fan ZK; Pan L; Jin LM
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):236-244. PubMed ID: 28603091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Li D; Chen C; Zhou Y; Chen R; Fan X; Bi Z; Li Z; Liu Y
    Medicine (Baltimore); 2015 Sep; 94(35):e1345. PubMed ID: 26334891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unresectable pancreatic adenocarcinoma treated with palladium-103 implant and chemoradiation.
    Parikh S; Nori D
    J Clin Gastroenterol; 1998 Mar; 26(2):158-60. PubMed ID: 9563935
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of adjuvant therapy in the management of pancreatic cancer.
    Laheru D; Yeo CJ
    Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiotherapy improves survival in unresectable pancreatic cancer: small trial but big (and credible) results.
    Ben-Josef E; Taylor JM; Lawrence TS
    J Clin Oncol; 2012 May; 30(13):1565-6; author reply 1566-7. PubMed ID: 22412130
    [No Abstract]   [Full Text] [Related]  

  • 36. Locally advanced pancreatic cancer: where should we go from here?
    Philip PA
    J Clin Oncol; 2011 Nov; 29(31):4066-8. PubMed ID: 21969514
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of radiation therapy in the management of locally advanced pancreatic cancer.
    Aref A; Berri R
    J Clin Oncol; 2012 May; 30(13):1564-5; author reply 1566-7. PubMed ID: 22412127
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.